You just read:

OncoSec Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following Modifications to IL-12 Gene Delivery Therapy at AACR Annual Meeting

News provided by

OncoSec Medical Incorporated

03 Apr, 2017, 08:01 ET